Payment integrity Claim audit
Centene · payment integrity
Audit queue/ AUD-2026-04-0001/ CLM-0000024
Claim 24 of 25 Previous Next claim Back to queue

Post-pay review · Bayou Oncology Associates

Medicare Advantage Member MBR-30884201 DOS 24 Feb 2026 Paid 10 Mar 2026 · $3,083.85 Recovery window closes in 39 days
Eligibility: Active on the date of service Wellcare Medicare Advantage HMO · Louisiana Prior auth: Approved and matched Drug and biologic
Review closing letter

As paid vs. as it should have been

No variance
LnCodeDescription PaidShould be VarianceResult
1 J9355 Injection, trastuzumab, excludes biosimilar, 10 mg
C50.911 · Malignant neoplasm of right female breast, unspecified site
$3,083.85 $3,083.85 Correct

Determination

No defect in any layer

Reviewed with no variance. Every line was paid at the allowable on file.

How it was coded

Coded as documented
Billed J9355 × 42 units — 420 mg
Supported by the record J9355 × 42 units — 420 mg, per the medication administration record

Remedy: None — the claim was billed and priced as the record supports

420 mg divided by the code's 10 mg billing unit is 42 units. The claim, the record and the authorization all say the same number — under CPP-061 v1.4, the version in force when the drug was given. v2.0 arrived five days later.

Prior authorization

Approved and matched
Authorization PA-2026-211730
Approved 2026-02-06
Valid 2026-02-10 → 2026-05-10
What was authorised Trastuzumab 420 mg per cycle, every three weeks
What was billed 42 units on 24 Feb 2026 — 420 mg, exactly as authorised

The same provider, the same benefit and the same policy as CLM-0000021, and here the units reconcile. This is what the drug-spend criterion is measured against: without the claims it clears, the ones it catches prove nothing.

Policy applied

Knowledge Center

Resolved as at the date of service, 24 Feb 2026 — not as at today.

CPP-061 Physician-administered drugs — dose, units and wastage Decisive

Governs how billed units are reconciled against the documented dose. Resolves to v1.4 here, not the v2.0 an auditor would find today

In force on 24 Feb 2026: v1.4 effective 2024-07-01 now v2.0
From CPP-061 v1.4, retrieved for this claim

code and setting are payable as submitted. No further reconciliation against the clinical record is required for a claim within the ceiling. 2.2 Units above the ceiling Units above the Medically Unlikely Edit ceiling are reviewed against the clinical record. The reviewer requests the medication administration record…

2.3 Unit calculation Where reconciliation is required, billed units equal the administered dose divided by the billing unit published in the HCPCS long descriptor, rounded to whole units. 2.4 Wastage Drug discarded from a single-dose vial is payable where the discarded amount is recorded in the clinical record…

This policy has changed since the service. v1.4 governed this claim; v2.0 took effect on 2026-03-01 and is what the library shows today. Billed units must now reconcile to the administered dose recorded in the infusion record. Passing the MUE ceiling is no longer sufficient on its own. Discarded single-dose-vial drug is payable only on a separate line carrying modifier JW; a line with no wastage requires JZ.
CPP-080 Eligibility, enrolment and retroactive termination Supporting

Coverage on the date of service, and the re-verification at audit

In force on 24 Feb 2026: v6.1 effective 2026-01-01

v6.1 was extracted from CPP-080_eligibility-enrolment-retroactive-termination_v6.1.md. Passages are quoted only on the policy the finding rests on.

CPP-085 Prior authorization and post-service review Supporting

The authorization on file, and what it closes off from post-service review

In force on 24 Feb 2026: v3.4 effective 2025-11-01

v3.4 was extracted from CPP-085_prior-authorization-post-service-review_v3.4.md. Passages are quoted only on the policy the finding rests on.

Source document

Open all four views
837P_20260227_391599.edi
Availity clearinghouse · EDI 837P · received 27 Feb 2026 08:31 · claim control CCN-8817223789
Claim form As received EDI Remittance

How this was decided

Open the full trace

Walked through Drug and biologic unit review v1.2, signed off 2026-02-20.

Procedure SOP-DRX-01 — Physician-administered drugs billed on the medical benefit
Nodes walked 13
Model calls 0 — every node that resolved did so on a rule, a lookup or arithmetic
06 Feb 10:05 Prior authorization PA-2026-211730 approved, 420 mg per cycle Utilization management
10 Mar 09:30 Claim paid, $3,083.85 released to provider Payment cycle
02 Apr 18:02 Selected by drug and biologic spend criteria Autonomize
02 Apr 18:03 CPP-061 resolved to v1.4 — the version in force on 24 Feb 2026, not the v2.0 that is current today Autonomize
07 Apr 09:30 Reviewed, no finding D. Mercer